نتایج جستجو برای: diabetes treatments

تعداد نتایج: 464423  

Journal: :Symmetry 2022

Although the advantages and disadvantages of asymmetrical thiazolidinediones as insulin-sensitizers have been well-studied, relevance symmetry asymmetry for biguanides has scarcely explored. Regarding symmetrical molecules, only one thiazolidinedione no evaluated proposed an antihyperglycemic agent treating type 2 diabetes. Since molecular structure defines physicochemical, pharmacological, tox...

2009
M Al-Maatouq M Al-Arouj S H Assaad S N Assaad S T Azar A A K Hassoun N Jarrah S Zatari K G M M Alberti

AIMS Increases in the prevalence of type 2 diabetes will likely be greater in the Middle East and other developing countries than in most other regions during the coming two decades, placing a heavy burden on regional healthcare resources. METHODOLOGY Medline search, examination of data from major epidemiological studies in the Middle Eastern countries. RESULTS The aetiology and pathophysio...

2016
Margaret Bannister Jenny Berlanga

Type 2 diabetes is a progressive condition that may require the combination of three oral treatments to achieve optimal glycemic management to prevent microvascular and macrovascular complications whilst minimizing the risk of acute complications and side effects or adverse reactions to treatments. With the widening availability of treatment options and increasing importance of individualized t...

2003
DAVID M. PARISER

cancer, arthritis, hypertension, heart disease, diabetes, and depression (Rapp 1999). In the last decade, a new understanding about the pathophysiology of psoriasis has resulted in the development of a new class of agents for these patients: targeted biologic therapy. These novel treatments target specific immunologic processes involved in the genesis of this disease, providing significant clin...

Journal: :P & T : a peer-reviewed journal for formulary management 2016
Walter Alexander

We present EULAR sessions on the latest treatments for rheumatic disease with an infliximab biosimilar, certolizumab pegol, secukinumab, and bimekizumab. We also report on significant developments in diabetes presented at ADA's Scientific Sessions.

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید